AOTI (AOTI) H1 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 TU earnings summary
6 Oct, 2025Executive summary
Strong trading in Q2 offset slower start in January and February, leading to robust H1 performance.
Confident in meeting market expectations for full year 2024, with revenue growth projected above 30%.
Financial highlights
Expected H1 2024 revenue of approximately $26.3 million, up 26.5% from H1 2023 ($20.8 million).
Net proceeds of £13.5 million (about $17.5 million) raised via AIM IPO in June 2024.
Outlook and guidance
Anticipates greater than 30% revenue growth for full year 2024.
Confident in meeting market expectations for the year.
Unaudited interim results for H1 2024 to be reported on 16 September 2024.
Partial view of Summaries dataset, powered by Quartr API
Latest events from AOTI
- FY 2025 revenue rose 14% to $66.5M, with growth despite Arizona Medicaid headwinds.AOTI
H2 2025 TU23 Feb 2026 - 26.4% revenue growth, margin gains, and IPO proceeds drive expansion and debt reduction.AOTI
H1 202420 Jan 2026 - Revenue up 32.9% to $58.4M, with margin gains and expanded Medicaid access.AOTI
H2 20247 Jan 2026 - H1 2025 revenue up 20.9% to $31.8m, with Medicaid and VA growth and key global validation milestones.AOTI
H1 202517 Dec 2025 - Revenue up 32% to $58.1m, margins and growth outlook strong with new market expansion.AOTI
H2 2024 TU6 Oct 2025 - H1 2025 revenue up 18%, outlook trimmed amid US healthcare disruption; Medicaid access expands.AOTI
H1 2025 TU6 Oct 2025